Harduin-Lepers A, Shaper J H, Shaper N L
Cell Structure and Function Laboratory, Johns Hopkins School of Medicine, Baltimore, Maryland 21287.
J Biol Chem. 1993 Jul 5;268(19):14348-59.
The beta 1,4-galactosyltransferase (beta 1,4-GT) gene is unusual in that it specifies two mRNAs in somatic cells of 3.9 and 4.1 kilobases (kb). These two transcripts arise as a consequence of initiation at two different sets of start sites that are separated by approximately 200 base pairs. Translation of each mRNA results in the predicted synthesis of two related protein isoforms that differ only in the length of their NH2-terminal cytoplasmic domain (Russo, R.N., Shaper, N. L., and Shaper, J.H. (1990) J. Biol. Chem. 265, 3324-3331). In this study we show that the cellular requirements for beta 1,4-GT correlate with the transcriptional start site used. In cells and tissues that express low transcript levels, the 4.1-kb transcriptional start site is apparently used exclusively. Increased transcription from the 4.1-kb start site plus low levels of transcription from the 3.9-kb start site result in the intermediate beta 1,4-GT transcript levels that are found in almost all somatic cell types. However, in mid- to late pregnant and lactating mammary glands very high transcript levels are observed, which correlate with the predominant use of the 3.9-kb transcriptional start site. To identify the cis-acting elements that regulate the use of the two transcriptional start sites, we constructed a series of beta 1,4-GT/CAT hybrids and carried out transient transfection assays using mouse L cells and Drosophila SL2 cells. These studies have delineated both a distal and proximal regulatory region just upstream of the 4.1- and 3.9-kb transcriptional start sites, respectively. In addition, a negative cis-acting regulatory region was identified that represses transcription from the proximal site. These results suggest a model of transcriptional regulation in which the distal region functions as a housekeeping promoter while the proximal region functions as a mammary cell-specific promoter. Differential initiation from the two promoters is a mechanism for regulation of beta 1,4-GT enzyme levels. The predictions from this model are consistent with the conclusion that both protein isoforms are functionally equivalent resident trans-Golgi membrane-bound enzymes.
β1,4-半乳糖基转移酶(β1,4-GT)基因不同寻常之处在于,它在体细胞中可产生两种长度分别为3.9和4.1千碱基(kb)的mRNA。这两种转录本是由起始于两组不同起始位点所导致的,这两组起始位点相隔约200个碱基对。每种mRNA的翻译都会产生两种相关的蛋白质异构体,它们仅在NH2末端胞质结构域的长度上有所不同(Russo, R.N., Shaper, N. L., and Shaper, J.H. (1990) J. Biol. Chem. 265, 3324 - 3331)。在本研究中,我们表明β1,4-GT的细胞需求与所使用的转录起始位点相关。在表达低转录水平的细胞和组织中,显然仅使用4.1-kb的转录起始位点。从4.1-kb起始位点增加的转录加上来自3.9-kb起始位点的低水平转录,导致了几乎在所有体细胞类型中都能发现的中等β1,4-GT转录水平。然而,在妊娠中后期和哺乳期的乳腺中,观察到非常高的转录水平,这与主要使用3.9-kb转录起始位点相关。为了鉴定调控两个转录起始位点使用的顺式作用元件,我们构建了一系列β1,4-GT/CAT杂种,并使用小鼠L细胞和果蝇SL2细胞进行瞬时转染分析。这些研究分别在4.1-和3.9-kb转录起始位点上游划定了一个远端和近端调控区域。此外,还鉴定出一个负性顺式作用调控区域,它可抑制近端位点的转录。这些结果提示了一种转录调控模型,其中远端区域起管家启动子的作用,而近端区域起乳腺细胞特异性启动子的作用。来自两个启动子的差异起始是调节β1,4-GT酶水平的一种机制。该模型的预测结果与两种蛋白质异构体都是功能等效的驻留反式高尔基体膜结合酶这一结论一致。